Yeqin is a PhD candidate interested in cancer immunology and immunotherapies. He utilizes multi-omics approaches to understand the dynamics, specificities and phenotypes of leukemia-specific T cells and improve graft-versus-leukemia responses after allogeneic hematopoietic stem cell transplantation. Yeqin holds a master degree of medicine in hematology and completed his residency training program as physician in the Department of Hematology, the First Affiliated Hospital of Nanjing Medical University.
Penter Lab
Cancer and immune cell co-evolution at Charité - Universitätsmedizin Berlin